Use of Rehab After Ischemic Stroke Varies in Acute Care
There is considerable variation in the use of rehabilitation services in the acute care setting following ischemic stroke.
Ischemic Stroke
Alteplase Seems Beneficial at 4.5 to 9.0 Hours After Stroke
HealthDay News — The use of alteplase between 4.5 and 9.0 hours after stroke onset results in a higher number of patients with no or minor neurological deficits, according to a study published in the May 9 issue of the New England Journal of Medicine. Henry Ma, PhD, from the University of Melbourne in Australia,…
Neurofilament Light: Biomarker of Neuroaxonal Injury After Ischemic Stroke
Investigators explored the use of serum neurofilament light chain as a biomarker for primary and secondary neuroaxonal injury after ischemic stroke.
Alteplase Non-Superior to Aspirin for Improving 90-Day Functional Outcome in Acute Ischemic Stroke
Alteplase may increase the risk for symptomatic intracranial hemorrhage vs aspirin.
Adhesive Interaction Between Thrombus and Stent Retriever Predominate in Ischemic Stroke
More adhesive-type interactions were observed between the thrombus and stent-retriever after thrombectomy in patients with acute ischemic stroke.
Alteplase Good for Ischemic Stroke With Unknown Onset Time
For patients with ischemic stroke with an unknown time of onset, intravenous alteplase is associated with better functional outcome than placebo.
Congenital Heart Disease, Hispanic Ethnicity Associated With Increased Mortality in Pediatric Arterial Ischemic Stroke
The investigators were unable to determine which type of congenital heart disease or which type of ventricular assist device, if used, played a role in mortality outcomes.
Tenecteplase Improves Reperfusion and Functional Outcome in Ischemic Stroke
The findings from this trial are limited to only ischemic stroke patients with large-vessel occlusion who are deemed appropriate for thrombolysis.
Ceftriaxone More Cost-Effective Than Standard Care for Post-Stroke Infection Prevention
There were no differences between the ceftriaxone and standard care groups in terms of institutional care resources, out-of-pocket expenses, or productivity losses.
Sickle Cell Trait Does Not Reliably Predict Ischemic Stroke in African Americans
Sickle cell trait is not associated with ischemic stroke and should not be relied upon as a sole predictor of stroke in African Americans.
Next post in Stroke
